A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Conditions: Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery Interventions: Drug: SHR-2004; Drug: Enoxaparin Sodium Injection; Rivaroxaban Tablets Sponsors: Beijing Suncadia Pharmaceuticals Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Lovenox | Ovarian Cancer | Ovaries | Research | Sodium | Study | Thrombosis